Cite
HARVARD Citation
Ditters, I. et al. (2022). Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe Consortium. Lancet. pp. 28-37. [Online].